Insulin-Induced Gene 1-Enhance Secretion of BMSC Exosome Enriched in miR-132–3p Promoting Wound Healing in Diabetic Mice
Molecular Pharmaceutics · 2024
DOI: 10.1021/acs.molpharmaceut.4c00322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Liming Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: China Academy of Chinese Medical Sciences, Beijing 100102, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Exosomes, Mesenchymal Stem Cells, MicroRNAs. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: China Postdoctoral Science Foundation.
Themen: Wundversorgung
Abstract (Originalsprache)
Chronic diabetic wounds represent a significant clinical challenge because of impaired healing processes, which require innovative therapeutic strategies. This study explores the therapeutic efficacy of insulin-induced gene 1-induced bone marrow mesenchymal stem cell exosomes (Insig1-exos) in promoting wound healing in diabetic mice. We demonstrated that Insig1 enhanced the secretion of bone marrow mesenchymal stem cell-derived exosomes, which are enriched with miR-132-3p. Through a series of in vitro and in vivo experiments, these exosomes significantly promoted the proliferation, migration, and angiogenesis of dermal fibroblasts under high-glucose conditions. They also regulated key wound-healing factors, including matrix metalloproteinase-9, platelet-derived growth factor, vascular endothelial growth factor, transforming growth factor-β1, and platelet endothelial cell adhesion molecule-1, thereby accelerating wound closure in diabetic mice. Histological analysis showed that Insig1-exos were more effective in promoting epithelialization, enhancing collagen deposition, and reducing inflammation. Additionally, inhibition of miR-132-3p notably diminished these therapeutic effects, underscoring its pivotal role in the wound-healing mechanism facilitated by Insig1-exos. This study elucidates the molecular mechanisms through which Insig1-exos promotes diabetic wound healing, highlighting miR-132-3p as a key mediator. These findings provide new strategies and theoretical foundations for treating diabetes-related skin injuries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- China Academy of Chinese Medical Sciences, Beijing 100102, China.
- Botanical Institute, Karlsruhe Institute for Technology, Fritz Haber Weg 4, 76131 Karlsruhe, Germany.
- Hubei Provincial Hospital of Traditional Chinese Medicine Affiliated to Hubei University of Chinese Medicine, Wuhan, Hubei 430061, China.
- The First Affiliated Hospital of Xiamen University, Xiamen ,Fujian 361000, China.
ORCID-Profile: Zhenyu Cai
Förderung
- China Postdoctoral Science Foundation
Zitieren
APA
Zheng, L., Song, H., Li, Y., Li, H., Lin, G., & Cai, Z. (2024). Insulin-Induced Gene 1-Enhance Secretion of BMSC Exosome Enriched in miR-132–3p Promoting Wound Healing in Diabetic Mice. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00322
Vancouver
Zheng L, Song H, Li Y, Li H, Lin G, Cai Z. Insulin-Induced Gene 1-Enhance Secretion of BMSC Exosome Enriched in miR-132–3p Promoting Wound Healing in Diabetic Mice. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00322
BibTeX
@article{Zheng2024,
author = {Zheng, Liming and Song, Honghong and Li, Yang and Li, Hengfei and Lin, Guanlin and Cai, Zhenyu},
title = {Insulin-Induced Gene 1-Enhance Secretion of BMSC Exosome Enriched in miR-132–3p Promoting Wound Healing in Diabetic Mice},
journal = {Molecular Pharmaceutics},
year = {2024},
doi = {10.1021/acs.molpharmaceut.4c00322}
}
EUVIMED